| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insight Molecular Diagnostics Inc. (IMDX) has 7 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. IMDX is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 12.68M | $67.99M | - | |
| CEO | 400.0K | $2.14M | - | |
| CFO | 201.2K | $1.08M | - | |
| Dir | 136.6K | $731.9K | - | |
| Dir | 39.5K | $211.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2020 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 1,391,466 | $2.16 | $3,000,000.70 | +2.7% | |
| Nov 13, 2019 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 1,176,471 | $1.70 | $2,000,000.70 | +5.0% | |
| Sep 17, 2019 | Arno Andrew | Director | Buy | 50,000 | $2.16 | $108,130.00 | +95.3% | |
| Sep 13, 2019 | Kalajian Tony T | Svp-chief Accounting Officer | Buy | 10,000 | $1.98 | $19,800.00 | New | |
| Sep 12, 2019 | Levine Mitchell S | Chief Financial Officer | Buy | 10,000 | $2.01 | $20,060.00 | New | |
| Sep 11, 2019 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 2,000,000 | $1.66 | $3,320,000.00 | +9.9% | |
| Jul 2, 2019 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 1,000,000 | $2.00 | $2,000,000.00 | +5.8% | |
| Feb 8, 2019 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 533,333 | $3.75 | $1,999,998.75 | +3.4% | |
| Jul 26, 2018 | Arno Andrew | Director | Buy | 52,447 | $0.00 | - | New | |
| Jul 26, 2018 | Annett William | President And CEO | Buy | 3,500 | $0.00 | - | New |